These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33623436)

  • 1. Lymphocyte-to-Monocyte Ratio is Associated with the Poor Prognosis of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
    Ma Y; Zhang J; Chen X
    Cancer Manag Res; 2021; 13():1571-1580. PubMed ID: 33623436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and prognostic value of ratios of platelet lymphocyte, neutrophil lymphocyte and lymphocyte monocyte in breast cancer patients.
    Song D; Li X; Zhang X
    Am J Transl Res; 2022; 14(5):3233-3239. PubMed ID: 35702097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between peripheral blood inflammatory indicators and pathologic complete response to neoadjuvant chemotherapy in locally advanced breast cancer patients.
    Eren T; Karacin C; Ucar G; Ergun Y; Yazici O; İmamoglu Gİ; Ozdemir N
    Medicine (Baltimore); 2020 May; 99(22):e20346. PubMed ID: 32481414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of lymphocyte-to-monocyte ratio in the preoperative setting for progression of patients with breast cancer.
    Goto W; Kashiwagi S; Asano Y; Takada K; Takahashi K; Hatano T; Takashima T; Tomita S; Motomura H; Hirakawa K; Ohira M
    BMC Cancer; 2018 Nov; 18(1):1137. PubMed ID: 30453914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Pretreatment Lymphocyte-to-Monocyte Ratio and Development of a Nomogram in Breast Cancer Patients.
    Yin Y; Zhang Y; Li L; Zhang S; Liu N; Yuan S
    Front Oncol; 2021; 11():650980. PubMed ID: 34976782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of the peripheral platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in predicting pathologic complete response after neoadjuvant chemotherapy in breast cancer patients.
    Jin X; Wang K; Shao X; Huang J
    Gland Surg; 2022 Jun; 11(6):1057-1066. PubMed ID: 35800742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of systemic immune-inflammatory markers before and after treatment for pathological complete response in patients undergoing neoadjuvant therapy for breast cancer: a retrospective study of 1994 patients.
    Wang H; Huang Z; Xu B; Zhang J; He P; Gao F; Zhang R; Huang X; Shan M
    Clin Transl Oncol; 2024 Jun; 26(6):1467-1479. PubMed ID: 38190034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio, and Lymphocyte-to-White Blood Cell Ratio in Colorectal Cancer Patients Who Received Neoadjuvant Chemotherapy.
    Jia W; Yuan L; Ni H; Xu B; Zhao P
    Technol Cancer Res Treat; 2021; 20():15330338211034291. PubMed ID: 34308689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of combined preoperative platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in patients undergoing surgery with stage IB non-small-cell lung cancer.
    Chen Y; Wang W; Zhang X; Yu X; Xi K; Wen Y; Wang G; Feng X; Zhang L
    Cancer Manag Res; 2018; 10():5411-5422. PubMed ID: 30519089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy.
    Marín Hernández C; Piñero Madrona A; Gil Vázquez PJ; Galindo Fernández PJ; Ruiz Merino G; Alonso Romero JL; Parrilla Paricio P
    Clin Transl Oncol; 2018 Apr; 20(4):476-483. PubMed ID: 28785911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel peripheral blood parameters as predictors of neoadjuvant chemotherapy response in breast cancer.
    Yang G; Liu P; Zheng L; Zeng J
    Front Surg; 2022; 9():1004687. PubMed ID: 36406359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients.
    Jia W; Wu J; Jia H; Yang Y; Zhang X; Chen K; Su F
    PLoS One; 2015; 10(11):e0143061. PubMed ID: 26580962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer.
    Meng X; Wang X; Jiang C; Zhang S; Cheng S
    Transl Oncol; 2022 Apr; 18():101355. PubMed ID: 35121221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Preoperative Serum Neutrophil to Lymphocyte Ratio (NLR), Platelet to Lymphocyte Ratio (PLR), and Lymphocyte to Monocyte Ratio (LMR) Predict Prognosis Following Radical Surgery for Pancreatic Adenocarcinomas? Results of a Retrospective Study.
    Gupta V; Chaudhari V; Shrikhande SV; Bhandare MS
    J Gastrointest Cancer; 2022 Sep; 53(3):641-648. PubMed ID: 34406625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
    Graziano V; Grassadonia A; Iezzi L; Vici P; Pizzuti L; Barba M; Quinzii A; Camplese A; Di Marino P; Peri M; Veschi S; Alberti S; Gamucci T; Di Gioacchino M; De Tursi M; Natoli C; Tinari N
    Breast; 2019 Apr; 44():33-38. PubMed ID: 30611095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low pretreatment lymphocyte/monocyte ratio is associated with the better efficacy of neoadjuvant chemotherapy in breast cancer patients.
    Peng Y; Chen R; Qu F; Ye Y; Fu Y; Tang Z; Wang Y; Zong B; Yu H; Luo F; Liu S
    Cancer Biol Ther; 2020; 21(2):189-196. PubMed ID: 31684807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
    Jiang C; Zhang S; Qiao K; Xiu Y; Yu X; Huang Y
    Clin Breast Cancer; 2022 Jul; 22(5):424-438. PubMed ID: 35428593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio in patients with osteosarcoma.
    Yapar A; Tokgöz MA; Yapar D; Atalay İB; Ulucaköy C; Güngör BŞ
    Jt Dis Relat Surg; 2021; 32(2):489-496. PubMed ID: 34145828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of the postoperative lymphocyte-to-monocyte and monocyte-to-red blood cell ratio in predicting locoregional and distant metastases after breast cancer resection - Retrospective study.
    Grupińska J; Budzyń M; Janowski J; Brzeziński J; Gryszczyńska B; Leporowska E; Formanowicz D; Kycler W
    Adv Med Sci; 2024 Mar; 69(1):103-112. PubMed ID: 38394965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of systemic inflammatory markers and development of a nomogram in breast cancer.
    Cho U; Park HS; Im SY; Yoo CY; Jung JH; Suh YJ; Choi HJ
    PLoS One; 2018; 13(7):e0200936. PubMed ID: 30048474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.